Kavitha Rajsekar
Biographic Data
| ID | 10027124 |
|---|---|
| NAME | Kavitha Rajsekar |
| GIVEN NAMES | Kavitha |
| FAMILY NAME | Rajsekar |
| SIGNATURE | RAJSEKAR K |
| AFFILIATIONS | Government of India |
| ORCID | 0000-0003-3042-8537 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2022 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 0 |
Financial toxicity of cancer treatment in India
Background The rising economic burden of cancer on patients is an important determinant of access to treatment initiation and adherence in India. Several publicly financed health insurance (PFHI) schemes have been launched in India, with treatment for cancer as an explicit inclusion in the health benefit packages (HBPs). Although, financial toxicity is widely acknowledged to be a potential consequence of costly cancer treatment, little is known a…
Tuberculosis Monitoring Encouragement Adherence Drive (TMEAD)
Introduction: Adherence to tuberculosis (TB) medication is one of the critical challenges to tuberculosis elimination in India. Digital adherence technologies (DAT) have the potential to facilitate medication adherence and monitor it remotely. Tuberculosis Monitoring Encouragement Adherence Drive (TMEAD) is one such DAT piloted in Nasik, Maharashtra, from April 2020 to December 2021. The study aims to assess the adherence and cost-effectiveness o…
No prominent works on this page.
Tuberculosis Monitoring Encouragement Adherence Drive (TMEAD)
Introduction: Adherence to tuberculosis (TB) medication is one of the critical challenges to tuberculosis elimination in India. Digital adherence technologies (DAT) have the potential to facilitate medication adherence and monitor it remotely. Tuberculosis Monitoring Encouragement Adherence Drive (TMEAD) is one such DAT piloted in Nasik, Maharashtra, from April 2020 to December 2021. The study aims to assess the adherence and cost-effectiveness o…
Financial toxicity of cancer treatment in India
Background The rising economic burden of cancer on patients is an important determinant of access to treatment initiation and adherence in India. Several publicly financed health insurance (PFHI) schemes have been launched in India, with treatment for cancer as an explicit inclusion in the health benefit packages (HBPs). Although, financial toxicity is widely acknowledged to be a potential consequence of costly cancer treatment, little is known a…
Internal Medicine (2 works) · Medicine (2 works) · Cancer (1 work) · Cancer treatment (1 work) · Diverse Scientific Research Studies (1 work) · Drug (1 work) · Drug adherence (1 work) · Economic and Financial Impacts of Cancer (1 work) · Economic growth (1 work) · Environmental health (1 work)